FBIOP
Price
$15.57
Change
+$0.22 (+1.43%)
Updated
Mar 1, 6:59 PM EST
ZLAB
Price
$21.10
Change
+$0.12 (+0.57%)
Updated
Mar 1, 6:59 PM EST
66 days until earnings call
Ad is loading...

FBIOP vs ZLAB ᐉ Comparison: Which is Better to Invest?

Header iconFBIOP vs ZLAB Comparison
Open Charts FBIOP vs ZLABBanner chart's image
Fortress Biotech
Price$15.57
Change+$0.22 (+1.43%)
Volume$5.63K
CapitalizationN/A
Zai Lab
Price$21.10
Change+$0.12 (+0.57%)
Volume$315.59K
CapitalizationN/A
View a ticker or compare two or three
FBIOP vs ZLAB Comparison Chart

Loading...

FBIOPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ZLABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FBIOP vs. ZLAB commentary
Mar 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBIOP is a Hold and ZLAB is a StrongBuy.

COMPARISON
Comparison
Mar 02, 2024
Stock price -- (FBIOP: $15.57 vs. ZLAB: $21.10)
Brand notoriety: FBIOP and ZLAB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FBIOP: 37% vs. ZLAB: 47%
Market capitalization -- FBIOP: $0 vs. ZLAB: $2.15B
FBIOP [@Biotechnology] is valued at $0. ZLAB’s [@Biotechnology] market capitalization is $2.15B. The market cap for tickers in the [@Biotechnology] industry ranges from $541.24B to $0. The average market capitalization across the [@Biotechnology] industry is $2.59B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FBIOP’s FA Score shows that 1 FA rating(s) are green whileZLAB’s FA Score has 0 green FA rating(s).

  • FBIOP’s FA Score: 1 green, 4 red.
  • ZLAB’s FA Score: 0 green, 5 red.
According to our system of comparison, FBIOP is a better buy in the long-term than ZLAB.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FBIOP’s TA Score shows that 3 TA indicator(s) are bullish while ZLAB’s TA Score has 4 bullish TA indicator(s).

  • FBIOP’s TA Score: 3 bullish, 6 bearish.
  • ZLAB’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ZLAB is a better buy in the short-term than FBIOP.

Price Growth

FBIOP (@Biotechnology) experienced а +1.24% price change this week, while ZLAB (@Biotechnology) price change was +5.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.02%. For the same industry, the average monthly price growth was +20.20%, and the average quarterly price growth was +48.09%.

Reported Earning Dates

ZLAB is expected to report earnings on May 07, 2024.

Industries' Descriptions

@Biotechnology (+7.02% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FBIOP with price predictions.
OPEN
A.I.dvisor published
a Summary for ZLAB with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FBIOP YTD gains are higher at: 34.918 vs. ZLAB (-22.795). FBIOP has higher annual earnings (EBITDA): -159.65M vs. ZLAB (-379.9M). ZLAB has more cash in the bank: 820M vs. FBIOP (99.5M). ZLAB has less debt than FBIOP: ZLAB (16.7M) vs FBIOP (70.1M). ZLAB has higher revenues than FBIOP: ZLAB (263M) vs FBIOP (81M).
FBIOPZLABFBIOP / ZLAB
CapitalizationN/A2.15B-
EBITDA-159.65M-379.9M42%
Gain YTD34.918-22.795-153%
P/E RatioN/AN/A-
Revenue81M263M31%
Total Cash99.5M820M12%
Total Debt70.1M16.7M420%
FUNDAMENTALS RATINGS
FBIOP vs ZLAB: Fundamental Ratings
FBIOP
ZLAB
OUTLOOK RATING
1..100
208
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
35
Fair valued
PROFIT vs RISK RATING
1..100
60100
SMR RATING
1..100
10096
PRICE GROWTH RATING
1..100
5050
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FBIOP's Valuation (1) in the null industry is somewhat better than the same rating for ZLAB (35) in the Biotechnology industry. This means that FBIOP’s stock grew somewhat faster than ZLAB’s over the last 12 months.

FBIOP's Profit vs Risk Rating (60) in the null industry is somewhat better than the same rating for ZLAB (100) in the Biotechnology industry. This means that FBIOP’s stock grew somewhat faster than ZLAB’s over the last 12 months.

ZLAB's SMR Rating (96) in the Biotechnology industry is in the same range as FBIOP (100) in the null industry. This means that ZLAB’s stock grew similarly to FBIOP’s over the last 12 months.

ZLAB's Price Growth Rating (50) in the Biotechnology industry is in the same range as FBIOP (50) in the null industry. This means that ZLAB’s stock grew similarly to FBIOP’s over the last 12 months.

ZLAB's P/E Growth Rating (100) in the Biotechnology industry is in the same range as FBIOP (100) in the null industry. This means that ZLAB’s stock grew similarly to FBIOP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FBIOPZLAB
RSI
ODDS (%)
Bearish Trend 1 day ago
37%
Bullish Trend 1 day ago
75%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
49%
Bearish Trend 1 day ago
81%
Momentum
ODDS (%)
Bearish Trend 1 day ago
50%
Bullish Trend 1 day ago
81%
MACD
ODDS (%)
Bearish Trend 1 day ago
53%
Bullish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
52%
Bullish Trend 1 day ago
78%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
49%
Bearish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 5 days ago
56%
Bullish Trend 1 day ago
79%
Declines
ODDS (%)
Bearish Trend 11 days ago
49%
Bearish Trend 18 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
44%
Bearish Trend 1 day ago
78%
Aroon
ODDS (%)
Bullish Trend 1 day ago
47%
Bearish Trend 1 day ago
89%
View a ticker or compare two or three
Ad is loading...
FBIOPDaily Signal changed days agoGain/Loss if shorted
 
Show more...
ZLABDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JAOSX44.50N/A
N/A
Janus Henderson Overseas T
WMMAX17.89N/A
N/A
TETON Westwood Mighty Mites A
RSLBX56.91N/A
N/A
American Funds SMALLCAP World R2
MSPTX10.06N/A
N/A
Morgan Stanley Inst Global Insgt C
HNIDX12.15N/A
N/A
Harbor Diversified Intl All Cp Retire

FBIOP and

Correlation & Price change

A.I.dvisor indicates that over the last year, FBIOP has been loosely correlated with ARAV. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if FBIOP jumps, then ARAV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBIOP
1D Price
Change %
FBIOP100%
+1.53%
ARAV - FBIOP
45%
Loosely correlated
N/A
EVGN - FBIOP
26%
Poorly correlated
+7.55%
NKTR - FBIOP
25%
Poorly correlated
+9.86%
ZLAB - FBIOP
23%
Poorly correlated
+0.57%
ASND - FBIOP
23%
Poorly correlated
+3.29%
More

ZLAB and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZLAB has been loosely correlated with BGNE. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ZLAB jumps, then BGNE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZLAB
1D Price
Change %
ZLAB100%
+0.57%
BGNE - ZLAB
42%
Loosely correlated
-0.38%
SRNEQ - ZLAB
42%
Loosely correlated
N/A
MDGL - ZLAB
38%
Loosely correlated
+6.71%
CRSP - ZLAB
37%
Loosely correlated
-0.58%
NTLA - ZLAB
34%
Loosely correlated
+1.68%
More